CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-13 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −261 | $456.03 | $119K | 65,409 |
| 2025-11-13 | Greenstreet Yvonne Chief Executive Officer | Option exercise · Performance Stock Option 2017 (right to buy) 10b5-1 | −10,000 | 0 | ||
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Option exercise 10b5-1 | +650 | $42.22 | $27K | 66,059 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Option exercise 10b5-1 | +15,000 | $119.13 | $1.8M | 81,059 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −711 | $448.07 | $319K | 80,348 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −2,132 | $449.15 | $958K | 78,216 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −453 | $450.17 | $204K | 77,763 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −1,255 | $451.16 | $566K | 76,508 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −1,210 | $452.43 | $547K | 75,298 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −1,069 | $453.52 | $485K | 74,229 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −1,960 | $454.84 | $891K | 72,269 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −3,406 | $455.56 | $1.6M | 68,863 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −2,420 | $456.64 | $1.1M | 66,443 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −604 | $457.71 | $276K | 65,839 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −430 | $458.42 | $197K | 65,409 |
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Option exercise · Performance Stock Option 2016 (right to buy) 10b5-1 | −650 | 0 | ||
| 2025-11-12 | Greenstreet Yvonne Chief Executive Officer | Option exercise · Performance Stock Option 2017 (right to buy) 10b5-1 | −15,000 | 10,000 | ||
| 2025-10-03 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −682 | $449.99 | $307K | 22,561 |
| 2025-10-03 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −810 | $450.63 | $365K | 21,751 |
| 2025-10-03 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −898 | $451.76 | $406K | 20,853 |
Page 18 of 41 · 816 trades